Foregut exclusion disrupts intestinal glucose sensing and alters portal nutrient and hormonal milieu

Diabetes

Volumn 64, Issue 6, 2015, Pages 1941-1950

  Pal, Atanu ^a,b   Rhoads, David B ^b,c   Tavakkoli, Ali ^a,b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCAGON LIKE PEPTIDE 1; GLUCOSE DERIVATIVE; INSULIN; SODIUM GLUCOSE COTRANSPORTER; SODIUM GLUCOSE COTRANSPORTER 3; UNCLASSIFIED DRUG; GLUCOSE; SLC5A1 PROTEIN, RAT; SODIUM GLUCOSE COTRANSPORTER 1;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG SELECTIVITY; ENDOCRINE FUNCTION; FOREGUT; GLUCOSE ABSORPTION; GLUCOSE BLOOD LEVEL; GLUCOSE INFUSION; GLUCOSE INTAKE; HORMONAL REGULATION; HORMONE RELEASE; INSULIN RELEASE; INTESTINE FUNCTION; MALE; NONHUMAN; NUTRIENT; PORTAL VEIN; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN SECRETION; RAT; ROUX Y ANASTOMOSIS; SMALL INTESTINE ABSORPTION; STOMACH BYPASS; TASTE BUD; VAGOTOMY; ANIMAL; GENETICS; GLUCOSE TOLERANCE TEST; IN VITRO STUDY; INTESTINE; METABOLISM; REAL TIME POLYMERASE CHAIN REACTION; SPRAGUE DAWLEY RAT;

ANIMALS; GLUCOSE; GLUCOSE TOLERANCE TEST; IN VITRO TECHNIQUES; INTESTINES; MALE; RATS; RATS, SPRAGUE-DAWLEY; REAL-TIME POLYMERASE CHAIN REACTION; SODIUM-GLUCOSE TRANSPORT PROTEINS; SODIUM-GLUCOSE TRANSPORTER 1;

EID: 84949253912     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db14-1578     Document Type: Article

References (32)

1. Schauer PR, Bhatt DL, Kirwan JP, et al.; STAMPEDE Investigators. Bariatric surgery versus intensive medical therapy for diabetes-3-year outcomes. N Engl J Med 2014;370:2002-2013.
2. Rubino F, Forgione A, Cummings DE, et al. The mechanism of diabetes control after gastrointestinal bypass surgery reveals a role of the proximal small intestine in the pathophysiology of type 2 diabetes. Ann Surg 2006;244:741-749.
3. Stearns AT, Balakrishnan A, Tavakkolizadeh A. Impact of Roux-en-Y gastric bypass surgery on rat intestinal glucose transport. Am J Physiol Gastrointest Liver Physiol 2009;297:G950-G957.
4. de Jonge, C, Rensen SS, Verdam FJ, et al. Endoscopic duodenal-jejunal bypass liner rapidly improves type 2 diabetes. Obes Surg 2013;23:1354-1360.
5. Stearns AT, Balakrishnan A, Rhoads DB, Tavakkolizadeh A. Rapid upregulation of sodium-glucose transporter SGLT1 in response to intestinal sweet taste stimulation. Ann Surg 2010;251:865-871.
6. Diez-Sampedro A, Hirayama BA, Osswald C, et al. A glucose sensor hiding in a family of transporters. Proc Natl Acad Sci U S A 2003;100:11753-11758.
7. Bhutta HY, Deelman TE, le Roux, CW, Ashley SW, Rhoads DB, Tavakkoli A. Intestinal sweet-sensing pathways and metabolic changes after Roux-en-Y gastric bypass surgery. Am J Physiol Gastrointest Liver Physiol 2014;307:G588- G593.
8. Burcelin R, Dolci W, Thorens B. Portal glucose infusion in the mouse induces hypoglycemia: Evidence that the hepatoportal glucose sensor stimulates glucose utilization. Diabetes 2000;49:1635-1642.
9. Delaere FI, Duchampt A, Mounien L, et al. The role of sodium-coupled glucose co- Transporter 3 in the satiety effect of portal glucose sensing. Mol Metab 2012;2:47-53.
10. Stearns AT, Balakrishnan A, Radmanesh A, Ashley SW, Rhoads DB, Tavakkolizadeh A. Relative contributions of afferent vagal fibers to resistance to diet-induced obesity. Dig Dis Sci 2012;57:1281-1290.
11. Bach Knudsen KE, Jørgensen H, Canibe N. Quantification of the absorption of nutrients derived from carbohydrate assimilation: model experiment with catheterised pigs fed on wheat- or oat-based rolls. Br J Nutr 2000;84: 449-458.
12. Mithieux G, Misery P, Magnan C, et al. Portal sensing of intestinal gluconeogenesis is a mechanistic link in the diminution of food intake induced by diet protein. Cell Metab 2005;2:321-329.
13. Freeman SL, Bohan D, Darcel N, Raybould HE. Luminal glucose sensing in the rat intestine has characteristics of a sodium-glucose cotransporter. Am J Physiol Gastrointest Liver Physiol 2006;291:G439-G445.
14. Margolskee RF, Dyer J, Kokrashvili Z, et al. T1R3 and gustducin in gut sense sugars to regulate expression of Na+-glucose cotransporter 1. Proc Natl Acad Sci U S A 2007;104:15075-15080.
15. Moran AW, Al-Rammahi MA, Arora DK, et al. Expression of Na+/glucose cotransporter 1 (SGLT1) is enhanced by supplementation of the diet of weaning piglets with artificial sweeteners. Br J Nutr 2010;104:637-646.
16. Steinert RE, Gerspach AC, Gutmann H, Asarian L, Drewe J, Beglinger C. The functional involvement of gut-expressed sweet taste receptors in glucosestimulated secretion of glucagon-like peptide-1 (GLP-1) and peptide YY (PYY). Clin Nutr 2011;30:524-532.
17. Sutherland K, Young RL, Cooper NJ, Horowitz M, Blackshaw LA. Phenotypic characterization of taste cells of the mouse small intestine. Am J Physiol Gastrointest Liver Physiol 2007;292:G1420-G1428.
18. Jang HJ, Kokrashvili Z, Theodorakis MJ, et al. Gut-expressed gustducin and taste receptors regulate secretion of glucagon-like peptide-1. Proc Natl Acad Sci U S A 2007;104:15069-15074.
19. Gerspach AC, Steinert RE, Schönenberger L, Graber-Maier A, Beglinger C. The role of the gut sweet taste receptor in regulating GLP-1, PYY, and CCK release in humans. Am J Physiol Endocrinol Metab 2011;301:E317-E325.
20. Gribble FM, Williams L, Simpson AK, Reimann F. A novel glucose-sensing mechanism contributing to glucagon-like peptide-1 secretion from the GLUTag cell line. Diabetes 2003;52:1147-1154.
21. Kuhre RE, Frost CR, Svendsen B, Holst JJ. Molecular mechanisms of glucosestimulated GLP-1 secretion from perfused rat small intestine. Diabetes 2015;64:370-382.
22. Fujita Y, Wideman RD, Speck M, et al. Incretin release from gut is acutely enhanced by sugar but not by sweeteners in vivo. Am J Physiol Endocrinol Metab 2009;296:E473-E479.
23. Vahl TP, Tauchi M, Durler TS, et al. Glucagon-like peptide-1 (GLP-1) receptors expressed on nerve terminals in the portal vein mediate the effects of endogenous GLP-1 on glucose tolerance in rats. Endocrinology 2007;148:4965- 4973.
24. Nishizawa M, Nakabayashi H, Uchida K, Nakagawa A, Niijima A. The hepatic vagal nerve is receptive to incretin hormone glucagon-like peptide-1, but not to glucose-dependent insulinotropic polypeptide, in the portal vein. J Auton Nerv Syst 1996;61:149-154.
25. Nakabayashi H, Nishizawa M, Nakagawa A, Takeda R, Niijima A. Vagal hepatopancreatic reflex effect evoked by intraportal appearance of tGLP-1. Am J Physiol 1996;271:E808-E813.
26. Nishizawa M, Nakabayashi H, Uehara K, Nakagawa A, Uchida K, Koya D. Intraportal GLP-1 stimulates insulin secretion predominantly through the hepatoportal-pancreatic vagal reflex pathways. Am J Physiol Endocrinol Metab 2013;305:E376-E387.
27. Nishizawa M, Moore MC, Shiota M, et al. Effect of intraportal glucagon-like peptide-1 on glucose metabolism in conscious dogs. Am J Physiol Endocrinol Metab 2003;284:E1027-E1036.
28. Damholt AB, Kofod H, Buchan AM. Immunocytochemical evidence for a paracrine interaction between GIP and GLP-1-producing cells in canine small intestine. Cell Tissue Res 1999;298:287-293.
29. Hansen CF, Vrang N, Sangild PT, Jelsing J. Novel insight into the distribution of L-cells in the rat intestinal tract. Am J Transl Res 2013;5:347-358.
30. Mace OJ, Schindler M, Patel S. The regulation of K- And L-cell activity by GLUT2 and the calcium-sensing receptor CasR in rat small intestine. J Physiol 2012;590:2917-2936.
31. Gorboulev V, Schürmann A, Vallon V, et al. Na(+)-D-glucose cotransporter SGLT1 is pivotal for intestinal glucose absorption and glucose-dependent incretin secretion. Diabetes 2012;61:187-196.
32. Muñoz R, Carmody JS, Stylopoulos N, Davis P, Kaplan LM. Isolated duodenal exclusion increases energy expenditure and improves glucose homeostasis in diet-induced obese rats. Am J Physiol Regul Integr Comp Physiol 2012;303: R985-R993.